Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517044 | SCV000614644 | benign | not specified | 2017-02-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000517044 | SCV000721472 | likely benign | not specified | 2017-07-28 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000648609 | SCV000770429 | benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004705636 | SCV005222315 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004541615 | SCV004775441 | benign | PLEC-related disorder | 2024-01-03 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |